ZLAB - Your Daily Pharma Scoop: Omeros Positive Five Prime's Milestone
Welcome to the Daily Pharma Scoop, a daily feature from the creators of the Total Pharma Tracker, a popular biopharma Marketplace service here on Seeking Alpha. In the daily scoop, we focus in on one key investment concept from the biopharma space and also provide quick commentary on other important news and a set of selected links to major news from the day before.
Omeros's OMS721 shows positive effect in Phase 2 trial of IgA nephropathy
Yesterday, Omeros (OMER), which is a stock we have extensively covered, announced results from a phase 2